title: Comparable beneficial effects of defibrotide and nifedipine in calcium induced atherosclerosis.
abstract: The present study demonstrates the antiatherosclerotic property of Defibrotide (DFT) in an experimental model in which the pathology is secondary to calcium deposition in the vessel wall and various organs. Rats were treated by gavage for 21 consecutive days with Vitamin D3 and/or, twice a day, with DFT or Nifedipine (N). The calcium contents of aorta, heart and kidney were determined by atomic absorption spectrometry. Specimens of these tissues were examined histologically. DFT or N administered alone did not modify the calcium contents of aorta, heart or kidney. On the contrary, Vitamin D3 caused a huge increase in the calcium concentration in the aorta and in the kidney, whereas the heart content was only double that of control animals. In rats treated with Vitamin D3, contemporaneous administration of DFT or N sharply and highly significantly reduced the aorta calcium concentration and there were less striking, although still significant, reductions in the other two tissues. Histological examination paralleled these data; the effect of DFT or N in reducing the mineralization of aorta and heart was very evident, and more pronounced for DFT. These results confirm that DFT, even though not belonging to the class of the calcium antagonists, has comparable antiatherosclerotic properties, possibly due to its endothelial protective efficacy, as evidenced by the lesser amount of calcium in the aortic tissue.
authors.affiliation: Crinos Biological Research Laboratories, Villa Guardia (Como), Italy.
authors.forename: R
authors.initials: R
authors.lastname: Porta
authors.forename: A
authors.initials: A
authors.lastname: Conz
authors.forename: A
authors.initials: A
authors.lastname: Conto
authors.forename: R
authors.initials: R
authors.lastname: Pescador
authors.forename: M
authors.initials: M
authors.lastname: Mantovani
authors.forename: L
authors.initials: L
authors.lastname: Ferro
mesh_terms: D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy*; D001835:Body Weight / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use*; D011089:Polydeoxyribonucleotides / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats
chemical_list: D002121:Calcium Channel Blockers; D011089:Polydeoxyribonucleotides; C036901:defibrotide; D009543:Nifedipine; D002118:Calcium